Market Exclusive

Analyst Activity – HC Wainwright Initiates Coverage On NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX) With a Buy

Analyst Ratings For NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX)

Today, HC Wainwright initiated coverage on NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX) with a Buy with a price target of $61.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX)
NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX) has insider ownership of 15.92% and institutional ownership of 60.93%.

Recent Trading Activity for NASDAQ:GTHX – G1 Therapeutics (NASDAQ:GTHX)
Shares of NASDAQ:GTHX – G1 Therapeutics closed the previous trading session at 49.50 down -0.56 1.12% with 50.529998779296875 shares trading hands.

Exit mobile version